Indication-Based Formulary Design Beginning in Contract Year (CY) 2020
Today, the Centers for Medicare & Medicaid Services (CMS) announced additional flexibilities in the Medicare Part D program to allow for innovative formulary design as a valuable approach to expand drug choices and address the challenge of high drug costs for seniors and government programs.
Newsroom Fact SheetSpeech: Remarks by CMS Administrator Seema Verma at the Pharmacy Quality Alliance Annual Meeting
Good afternoon, it’s a pleasure to be with you today. Pharmacists are on the front lines of patient care and have keen insight to the issues that patients face. We appreciate your hard work, and we look forward to working with you on a goal that I’m sure we share – ensuring that all patients can access their medications at an affordable price.
Newsroom Fact SheetCMS Strategy to Combat Medicare Part D Prescription Drug Fraud and Abuse
Prescription drug abuse is a serious and growing problem nationwide. Unfortunately, the Medicare Part D prescription drug program (Part D) is not immune from the abuses associated with this nationwide epidemic.
Newsroom Fact Sheet